Legislative and Regulatory Update | Legal and Regulatory Compliance

CMS and OIG Seek Input on Fraud Laws

Legislative and Regulatory Update | Legal and Regulatory Compliance

CMS and OIG Seek Input on Fraud Laws

Recognizing the transition to value-based payment and care coordination, HHS is asking interested parties to identify regulatory obstacles to achievement of that goal.

Current laws can hinder alternative payment models and care arrangements that were unheard of when the laws were first enacted.

Many readers will agree that two of the more complex and frustrating fraud laws are the Anti-Kickback statute and the Stark self-referral law. Each has a set of regulations that can trap the unwary—or even the hypercautious—and can hinder alternative payment models and other care arrangements that were unheard of when the laws were first enacted. 

Case in point: The Stark Law, formally known as The Ethics in Patient Referrals Act, has confounded healthcare providers for nearly 30 years and has spawned many regulations, exceptions, and safe harbors. The law has been criticized by many, and even its original sponsor, former Congressman Pete Stark, has been quoted as saying it should be repealed. But it remains on the books, continues to be the basis of fraud cases, and can be violated “innocently” because no intent to commit fraud is required. The Anti-Kickback statute is similarly complex and baffling to many.

There is some reason for hope, however. Seeking ways “to transform the healthcare system into one that pays for value,” and recognizing that “care coordination is a key aspect of systems that deliver value,” two agencies within the Department of Health and Human Services (HHS) have been asking interested parties to identify regulatory obstacles to achievement of that goal.

Early this summer the Centers for Medicare & Medicaid Services (CMS) asked for public comment on the Stark Law and received more than 300 replies. More recently, the HHS Office of Inspector General asked stakeholders for comments on the broad reach of the Anti-Kickback statute and its “beneficiary inducements” penalties as potential impediments to arrangements that would advance coordinated care.

It is unclear when or whether regulatory changes will result from these requests for information, but one can take heart that HHS is asking the right questions. Stay tuned.

Resources:


J. Stuart Showalter, JD, MFS, is a contributing editor for HFMA.

About the Author

J. Stuart Showalter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Legal and Regulatory Compliance

Blog | Claims Adjudication

Hospital groups express concern over earlier court ruling that could expand False Claims Act liability

The groups argue that allowing FCA claims to be brought for post-termination actions would defy congressional intent and leave hospitals subject to excessive financial liability.

Column | Healthcare Reform

Two infrastructure bills have significant implications for healthcare and bipartisanship

Congress’ handling of two mammoth bills may well determine the political tone in Washington and whether there will be any room for bipartisanship for the remainder of President Joe Biden’s term.

How To | Cost Effectiveness of Health

Financial Sustainability Report: June 2021

This June issue of the Financial Sustainability Report, sponsored by Kaufman Hall, leads off with results of HFMA’s recent report examining the evolving role of the healthcare CFO over the next decade. Two features also examine steps health systems can take to promote success with value-based payment initiatives, including developing models to inform their efforts with risk-based contracts and focusing efforts on removing impediments to success under such contracts.

News | Coronavirus

Healthcare News of Note: Trump administration diverted nearly $10 billion in funds slated for hospitals to Operation Warp Speed

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles, including the discovery that provider funds were used for Warp Speed operations, the need to retain the Medicare telehealth expansion and healthcare antitrust issues to watch.